Last update 01 Nov 2024

Sun Pharm Investments Ltd.

Startups
|
Private Company|
2017|
Canada
|
10-50
|
www.sunpharm.com

Overview

Basic Info

Introduction
Sun Pharm Investments is a business that operates in the field of medical cannabis cultivation. The company's areas of expertise include agriculture, technology, pharmaceutical sales, consumer packaged goods, international distribution, and brand marketing.

Tags

Immune System Diseases
Skin and Musculoskeletal Diseases
Infectious Diseases
Monoclonal antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases1
Immune System Diseases1
Top 5 Drug TypeCount
Monoclonal antibody1
Top 5 TargetCount
IL-23p19(Interleukin-23 subunit p19)1

Related

1
Drugs associated with Sun Pharm Investments Ltd.
Tildrakizumab-ASMN
Target
IL-23p19
Mechanism
IL-23p19 inhibitors
Active Org.
Almirall SAAlmirall SA [+6]
Originator Org.
Merck Sharp & Dohme Corp.Merck Sharp & Dohme Corp.
Active Indication
Plaque psoriasis [+3]
Inactive Indication
Ankylosing Spondylitis [+3]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date20 Mar 2018
100 Clinical Results associated with Sun Pharm Investments Ltd.
Login to view more data
0 Patents (Medical) associated with Sun Pharm Investments Ltd.
Login to view more data
100 Deals associated with Sun Pharm Investments Ltd.
Login to view more data
100 Translational Medicine associated with Sun Pharm Investments Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 16 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Tildrakizumab-ASMN
 ( IL-23p19 )		Plaque psoriasis
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free